RE:Hemophilia clarificationFDA clinical trials is a mulicenter trial which involves donor islet cells into SVA pouch to treat non responsive hypoglcemic patients - to which there is no cure. After 6 months, see if device is safe in humans, trial will focus on reaching clinically therapeutic levels. If preliminary results hit therapeutic clinical target levels, it will be a major break through and could expand the study.
Other colloboration involves encapsulated islet cells from porcine placed into the pouch. Here there is no need for anti rejection drugs. We dont have any data or info regading the outcome or which company is doing the preclinical work. Both could be a breakthrough in the treatment of diabetes.
So Seronova has several applications to its device. It will take some time, but in my opinion we should hear about some of these results before the end f the year.
Besides Diabetes, Hemophilia, thyroid disese can also be a potential source of revenue.
These are my opinions only. Please do your own due diligence read MDA, sedar documents etc. GLTA